Dr Reddy’s to market three Amgen drugs in India

By: |
New Delhi | Published: August 6, 2015 1:31:23 PM

Dr Reddy's Laboratories said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

pharma firms, pharma firms hike, pharma firms price hike, pharma firms hike in price, cancer drugs, condoms, condoms price, cancer drugs price, economy newsDr Reddy?s Laboratories said it has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India in oncology and cardiology.(PTI picture for representation only)

Dr Reddy’s Laboratories on Thursday said it has inked a pact with US-based biotechnology firm Amgen to market its three drugs used to treat heart diseases and cancer in India.

The Hyderabad-based firm said it has entered into a strategic collaboration with Amgen to market and distribute three Amgen medicines in India in oncology and cardiology, Dr Reddy’s Laboratories said in a statement.

Under the terms of the collaboration, Dr Reddy’s shall undertake a full range of regulatory and commercial services to seek approval and launch the three drugs — Kyprolis, Blincyto and Repatha — in India.

“The collaboration leverages capabilities of both companies, combining three of Amgen’s innovative therapies with Dr Reddy’s deep understanding of patient and physician needs in India,” the company said.

Dr Reddy’s Executive Vice-President and Head of India Business & Global Business Development Alok Sonig said that addressing significant unmet need of patients in oncology and cardiovascular is a key area in India and, therefore, a priority for Dr Reddy’s.

“We are pleased to be joining forces with Dr Reddy’s Laboratories in order to make Amgen’s innovative medicines available to patients in India,” Amgen VP and General Manager, Japan Asia Pacific Region, Penny Wan said.

Dr Reddy’s stock was trading at Rs 4,286.45 on BSE, up 2.18 per cent.

Get live Stock Prices from BSE and NSE and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Switch to Hindi Edition
FinancialExpress_1x1_Imp_Desktop